Bank Julius Baer & Co’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-33,389
| Closed | -$336K | – | 569 |
|
|
2023
Q4 | $336K | Sell |
33,389
-9
| -0% | -$91 | ﹤0.01% | 358 |
|
|
2023
Q3 | $313K | Buy |
33,398
+656
| +2% | +$6.15K | ﹤0.01% | 357 |
|
|
2023
Q2 | $803K | Sell |
32,742
-3,904
| -11% | -$95.7K | ﹤0.01% | 287 |
|
|
2023
Q1 | $853K | Buy |
36,646
+2,543
| +7% | +$59.2K | 0.01% | 284 |
|
|
2022
Q4 | $863K | Buy |
34,103
+2,223
| +7% | +$56.3K | 0.01% | 283 |
|
|
2022
Q3 | $615K | Sell |
31,880
-65,007
| -67% | -$1.25M | ﹤0.01% | 315 |
|
|
2022
Q2 | $2.47M | Sell |
96,887
-19,863
| -17% | -$506K | 0.02% | 197 |
|
|
2022
Q1 | $3M | Sell |
116,750
-18,779
| -14% | -$483K | 0.02% | 197 |
|
|
2021
Q4 | $5.68M | Sell |
135,529
-298,627
| -69% | -$12.5M | 0.03% | 191 |
|
|
2021
Q3 | $18.9M | Buy |
434,156
+98,644
| +29% | +$4.29M | 0.12% | 118 |
|
|
2021
Q2 | $15.9M | Buy |
335,512
+83,516
| +33% | +$3.95M | 0.1% | 143 |
|
|
2021
Q1 | $12.9M | Buy |
251,996
+105,245
| +72% | +$5.4M | 0.1% | 141 |
|
|
2020
Q4 | $3.93M | Buy |
146,751
+117,945
| +409% | +$3.16M | 0.03% | 208 |
|
|
2020
Q3 | $989K | Buy |
+28,806
| New | +$989K | 0.01% | 296 |
|